Arthritis induced with cartilage-specific antibodies is IL-4-dependent

European Journal of Immunology

Volumn 36, Issue 6, 2006, Pages 1608-1618

  Nandakumar, Kutty Selva ^a   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Arthritis; Collagen type II; IL 4; mAb; Th1 Th2

Indexed keywords

COLLAGEN ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; STAT4 PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CELL ACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DEPLETION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; IN VIVO STUDY; INCIDENCE; INFLAMMATION; JOINT DESTRUCTION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODY SPECIFICITY; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COLLAGEN; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; STAT4 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745357079     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535633     Document Type: Article

References (52)

1. Arend, W. P. and Dayer, J. M., Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995. 38: 151-160.
2. Feldmann, M., Brennan, F. M., Williams, R. O., Woody, J. N. and Maini, R. N., The transfer of a laboratory based hypothesis to a clinically useful therapy: The development of anti-TNF therapy of rheumatoid arthritis. Best Pract. Res. Clin. RheumatoL. 2004. 18: 59-80.
3. Mosmann, T. R. and Coffman R. L., Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
4. Miossec, P. and van den Berg, W., Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997. 40: 2105-2115.
5. Skapenko, A., Wendler, J., Lipsky, P. E., Kalden, J. R. and Schulze-Koops, H., Altered memory T cell differentiation in patients with early rheumatoid arthritis. J. Immunol. 1999. 163: 491-499.
6. Miossec, P., Chomarat, P., Dechanet, J., Moreau, J. F., Roux, J. P., Delmas, P. and Banchereau, J., Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 1994. 37: 1715-1722.
7. Lubberts, E., Joosten, L. A., Chabaud, M., van den Bersselaar, L., Oppers, B., Coenen-de Roo, C. J., Richards, C. D. et al., IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 2000. 105: 1697-1710.
8. Sigidin, Y. A., Loukina, G. V., Skurkovich, B. and Skurkovich, S., Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand. J. Rheumatol. 2001. 30: 203-207.
9. O'Shea, J. J., Ma, A. and Lipsky, P., Cytokines and autoimmunity. Nat. Rev. Immunol. 2002. 2: 37-45.
10. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paid, W. E., The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999. 17: 701-738.
11. Vannier, E., Miller, L. C. and Dinarello, C. A., Coordinated antiinflammatory effects of interleukin 4: Interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 1992. 89: 4076-4080.
12. Cope, A. P., Gibbons, D. L., Aderka, D., Foxwell, B. M., Wallach, D., Maini, R. N., Feldmann, M. and Brennan F. M., Differential regulation of tumour necrosis factor receptors TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synoviaL joint mononuclear cells. Cytokine 1993. 5: 205-212.
13. Dechanet, J., Briolay, J., Rissoan, M. C., Chomarat, P., Galizzi, J. P., Banchereau, J. and Miossec, P., IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 1993. 151: 4908-4917.
14. Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Girl, J. G. et al., Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 1993. 261: 472-475.
15. Joosten, L. A., Lubberts, E., Durez, P., Helsen M. M., Jacobs, M. J., Goldman, M. and van den Berg, W. B., Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 1997. 40: 249-260.
16. Horsfall, A. C., Butler, D. M., Marinova, L., Warden, P. J., Williams, R. O., Maini, R. N. and Feldmann, M., Suppression of collagen-induced arthritis by continuous administration of IL-4. J. Immunol. 1997. 159: 5687-5696.
17. Joosten, L. A., Lubberts, E., Helsen, M. M., Saxne, T., Coenen-de Roo, C. J., Heinegard, D. and van den Berg, W. B., Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1999. 1: 81-91.
18. Finnegan, A., Mikecz, K., Tan, P. and Glant, T. T., Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J. Immunol. 1999. 163: 5383-5390.
19. van Roon, J. A., Lafeber, F. P. and Bijlsma, J. W., Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 2001. 44: 3-12.
20. Whit, S. H., Kim, S., Evans, C. H., Ghivizzard, S. C., Oligino, T. and Robbins, P. D., Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J. Immunol. 2001. 166: 3499-3505.
21. Kageyama, Y., Koide, Y., Uchijima, M., Nagata, T., Yoshida, A., Talki, A., Miura, T. et al., Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis. Arthritis Rheum. 2004. 50: 968-975.
22. Svensson, L, Nandakumar, K. S., Johansson, A., Jansson, L. and Holmdahl, R., IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur. J. Immunol. 2002. 32: 2944-2953.
23. Nandakumar, K. S., Andren, M., Martinsson, P., Baftner, E., Helltrom S., Holmdahl, R. and Kleinau, S., Induction of arthritis by single monoclonal IgG anti-collagen type 11 antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur. J. Immunol. 2003. 33: 2269-2277.
24. Hietala, M. A., Nandakumar, X. S., Persson, L., Fahlen, S., Holmdahl, R. and Pekna, M., Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur. J. Immunol. 2004. 34: 1208-1216.
25. Nandakumar, K. S., Backlund, J., Vestberg, M. and Holmdahl, R., Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res. Ther. 2004. 6: R544-R550.
26. Nandakumar, K. S., Svensson, L. and Holmdahl, R., Collagen type II-specific monoclonal antibody-induced arthritis in mice: Description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 2003. 163: 1827-1837.
27. Reiner, S. L. and Locksley, R. M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
28. Pettit, A. R., Ji, H., von Stechow, D., Muller, R., Goldring, S. R., Choi, Y., Benoist, C. and Gravallese, E. M., TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 2001. 159: 1689-1699.
29. Bendixen, A. C., Shevde, N. K., Dienger, I- M., Willson, T. M., Funk C. D. and Pike, J. W., IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. USA 2001. 98: 2443-2448.
30. Abu-Amer, Y., IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. J. Clin. Invest. 2001. 107. 1375-1385.
31. Marinova-Mutafchieva, L., Williams, R. O., Mason, L. J., Mauri, C., Feldmann, M. and Maini, R. N., Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 1997. 107: 507-512.
32. Kagari, T., Doi, H. and Shimozato, T., The importance of IL-1beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immnunol. 2002. 169: 1459-1466.
33. Ortmann, R. A. and Shevach, E. M., Susceptibility to collagen-induced arthritis: Cytokine-mediated regulation. Clin. Immunol. 2001. 98: 109-118.
34. Chen, Y., Rosloniec, E., Goral, M. I., Boothby, M. and Chen, J., Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2R beta/IL-4R alpha chimeric cytokine receptor transgene. J. Immunol. 2001. 166: 4163-4169.
35. Lubberts, E., Joosten, L A., van den Bersselaar, L., Helsen, M. M., Bakker, A. C., van Meurs, J. B., Graham, F. L. et al., Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J. Immunol. 1999. 163: 4546-4556.
36. Joosten, L A., Helsen, M. M., van de Loo, F. A. and van den Berg, W. B., Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/ beta, and IL-1Ra. Arthritis Rheum. 1996. 39: 797-809.
37. Guedez, Y. B., Whittington, K. B., Clayton, I. L., Joosten, L. A., van de Loo, F. A., van den Berg, W. B. and Rosloniec, E. F., Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 2001. 44: 2413-2424.
38. Rosloniec, E. F., Latham, K. and Guedez, Y. B., Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res. 2002. 4: 333-336.
39. Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A. and Matthys, P., Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 1997. 158: 5507-5513.
40. Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S. et al., High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997. 158: 5501-5506.
41. Seitz, M., Napierski, I., Augustin, R., Hunstein, W. and Kirchner, H., Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis. Scand. J. Rheumatol. 1987. 16: 257-262.
42. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
43. Hom, J. T., Cole, H., Estridge, T. and Gliszczynski V. L., Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Clin. Immunol. Immunopathol. 1992. 62: 56-65.
44. Wooley, P. H., Whalen, J. D., Chapman D. L., Berger, A. E., Richard, K. A., Aspar, D. G. and Staite, N. D., The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 1993. 36: 1305-1314.
45. Williams, R. O., Feldmann, M. and Maini, R. N., Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1992. 89: 9784-9788.
46. Ohmura, K., Nguyen, L. T., Locksley, R. M., Mathis, D. and Benoist, C., Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis Rheum. 2005. 52: 1866-1875.
47. Ji, H., Gauguier, D., Ohmura, K., Gonzalez, A., Duchatelle, V., Danoy, P., Garchon, H. J. et al., Genetic influences on the end-stage effector phase of arthritis. J. Exp. Med. 2001. 194: 321-330.
48. Maccioni, M., Zeder-Lutz, G., Huang, H., Ebel, C., Gerber, P., Hergueux, J., Marchal P. et al., Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. 2002. 195: 1071-1077
49. Holmdahl, R., Rubin, K, Klareskog, L, Larsson, E. and Wigzell, H., Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986. 29: 400-410.
50. Schulte, S., Unger, C., Mo, J. A., Wendler, O., Bauer, E., Frischholz, S., von der Mark, K. et al., Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem. 1998. 273: 1551-1561.
51. Holmdahl, R., Carlsen, S., Mikulowska, A., Vestberg, M., Brunsberg, U., Hansson, A.-S., Sundvall, M. et al., Genetic analysis of mouse models for rheumatoid arthritis.In Adolph, YL W. (Ed.) Human genome methods. CRC Press, New York 1998, pp 215-238.
52. Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R. and Issazadeh-Navikas, S., IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 2003. 170: 4776-4784.